St. Antonius Hospital
antoniusziekenhuis.nlTotal trials
98
Active
24
Phase 3
9
Total enrollment
131,383
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 30-day DAPT | — | — | — | — | — | 1 | |
| Guideline-directed therapy | — | — | — | — | — | 1 | |
| Clopidogrel | — | — | — | 5 | |||
| PAiN - multimodal analgesia | — | — | — | — | — | 1 |
Next readouts
- 2026-06-15
- 2027-10-01
- 2028-07-01
Top conditions
- Coronary Artery Disease5
- Erectile Dysfunction5
- Prostate Cancer4
- Bleeding4
- Quality of Life4
- Aortic Valve Stenosis4
- Morbid Obesity4
- Myocardial Infarction3
Frequently asked questions about St. Antonius Hospital
- How many clinical trials does St. Antonius Hospital have on ClinicalTrials.gov?
- St. Antonius Hospital is listed as the lead sponsor on 98 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of St. Antonius Hospital's trials are in Phase 3?
- 9 of St. Antonius Hospital's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does St. Antonius Hospital focus on?
- St. Antonius Hospital's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Erectile Dysfunction, Prostate Cancer, Bleeding, Quality of Life.
- When are St. Antonius Hospital's next clinical trial readouts?
- St. Antonius Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy”, expected around 2026-06-15.